pyrazinamide has been researched along with Chromosome-Defective Micronuclei in 1 studies
pyrazinecarboxamide : A monocarboxylic acid amide resulting from the formal condensation of the carboxy group of pyrazinoic acid (pyrazine-2-carboxylic acid) with ammonia. A prodrug for pyrazinoic acid, pyrazinecarboxamide is used as part of multidrug regimens for the treatment of tuberculosis.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Masjedi, MR | 1 |
| Heidary, A | 1 |
| Mohammadi, F | 1 |
| Velayati, AA | 1 |
| Dokouhaki, P | 1 |
1 other study available for pyrazinamide and Chromosome-Defective Micronuclei
| Article | Year |
|---|---|
Chromosomal aberrations and micronuclei in lymphocytes of patients before and after exposure to anti-tuberculosis drugs.
Topics: Adolescent; Adult; Age Factors; Aged; Antibiotics, Antitubercular; Antitubercular Agents; Case-Contr | 2000 |